CRISPR Therapeutics (CRSP) PT Lowered to $80 at Citizens: Pipeline Not Valued
Tweet Send to a Friend
Citizens analyst Silvan Tuerkcan lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $80.00 (from $86.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
